Recent studies of stem cell behavior and stem cell niche have led to the development of complex three-dimensional (3D) organoid culture systems (1, 2). In the presence of specific biochemical and biophysical cues that mimic the in vivo microenvironment, stem cells constantly proliferate; some populations differentiate into multiple cell types, as are observed in organs. These cells then self-assemble into complex structures based on the same intrinsic organization principles of their tissue of origin. Compared with conventional two-dimensional (2D) cultures, 3D organoids better mimic the complex aspects of the target organ in terms of histology, metabolism, and functionality (3). Organoids can be initiated either from tissue-resident adult stem cells (ASCs) or from pluripotent stem cells (PSCs), including embryonic stem cells and induced PSCs (iPSCs).

Stimulation of the stem cell niche established by the extracellular matrix (ECM) and conditioned medium is essential for promoting the self-organization and differentiation of stem cells in culture. Organoids are commonly cultured in a 3D hydrogel system as scaffolds. Hydrogels can have various levels of modulus, topography, permeability, and biodegradability, all of which have profound effects on stem cell fate (4). ECM protein-based hydrogels are often used for organoid expansion, among which Matrigel is recognized as the “golden standard” material. Matrigel is a basement membrane extract, purified from Engelbreth-Holm-Swarm mouse sarcoma, which is mostly composed of laminin and collagen IV (5, 6). The applications of Matrigel over the recent years have greatly exceeded other biomaterials, since long to support organoid growth. However, Matrigel has limited use in translational therapies, chiefly because Matrigel is derived from mouse sarcoma and therefore contains tumor-derived growth factors and enzymes (5, 7, 8). Moreover, Matrigel cannot be easily manipulated to generate specific organoid niches for targeting organs, thereby suffering from limited maturation cell-responsiveness. Additionally, lot-to-lot variability owing to inherent compositional variation also limits the clinical application of this biomaterial. Accordingly, the development of alternative hydrogel systems that are amendable to the clinical setting and closely mimic the in vivo stem cell niche may increase the applications and versatility of organoid technology. Recent studies have evaluated various natural and synthetic hydrogels as alternatives to Matrigel. In this review, we aim at providing an overview on the use of ECM-based hydrogel systems as alternatives of Matrigel for organoid cultures. A variety of scaffolds have been explored for organoid cultures, including decellularized tissue-derived scaffolds, natural polymer- and synthetic polymer-based scaffolds (Table 1). We first briefly summarize key roles of ECM as stem cell niche.

Table 1 . Various types of biomaterials as alternatives of Matrigel for organoid culture

Materials	Material type	Cell type	Reference
Natural	Collagen	ASC-derived intestinal organoid	(12, 13)
		ASC-derived stomach organoid	(14)
		ASC-derived colon organoid	(14)
		ESC-derived kidney organoid	(15)
		Primary mammary epithelial cell-derived mammary organoid	(16)
	Alginate	PSC-derived intestinal organoid	(17, 18)
	Collagen–laminin–fibronectin–hyaluronan	Primary mammary epithelial cell-derived mammary organoid	(20)
	Fibrin–laminin	ASC-derived small intestinal, pancreatic and liver organoids	(22)
Decellularized tissue	Brain	PSC-derived brain organoid	(28, 29)
	Islet	ASC-derived islet organoid	(32, 33)
	Endometrium	ASC-derived endometrium organoid	(36)
	Testicle	ASC-derived testicular organoid	(35)
	Retina	ASC-derived retinal organoid	(34)
		ASC-derived intestinal organoid	(30, 31)
	Intestine	ASC-derived hepatocyte organoid	(31)
		ASC-derived pancreatic organoid	(31)
Synthetic	PEG	PSC-derived cardiac organoid	(38)
		ASC-derived intestinal enteroid and endometrial organoid	(37, 40)
		PSC-derived intestinal organoid	(37, 39)
		PSC-derived lung organoid	(37, 39)
	PLGA	PSC-derived intestinal organoid	(45, 46)
		PSC-derived lung organoid	(45)
	PCL	PSC-derived lung organoid	(45, 47)
	pNIPAM	ASC-derived intestinal organoid	(47)
	PVA	PSC-derived kidney organoid	(48)
Hybrid	PEG-fibrin	PSC-derived liver organoid	(44)
	PEG-gelatin	ASC-derived liver organoid	(43)

The ECM is a fibrous network of macromolecules that surrounds cells. Although the composition and organization of the ECM vary among organs, the major components include fibrous proteins, glycoproteins, proteoglycans, and glycosaminoglycans. In organs, the ECM has tissue-specific architecture with topographical cues and elastic properties that transmit biochemical and biomechanical signals. These signals regulate cell adhesion, migration, proliferation, and differentiation, thereby guiding cell fate and developmental processes (9). Thus, the specific dynamics of the ECM are almost inseparable from the identity of the cell within the organ. Stem cells can be directly affected by the mechanical properties of the ECM (10) via sensing of such external forces and can exert intrinsic forces accordingly. Interactions between the ECM and cells, mediated by integrins and other receptors, play key roles in transmitting signals to cells, leading to the activation of various signaling cascades (11). The ECM can also store and release growth factors and other signaling molecules, and ECM components can be released through ECM cleavage by proteases that regulate ECM architecture and influence cell behavior. Therefore, when recreating the stem cell niche in vitro by introducing matrices, the design should consider biochemical and mechanical factors. Here, we will introduce a range of biomaterials that have been shown to have applications as matrices for organoids, and we will discuss how these materials contribute to the ECM-like environment required for organoid growth.

Natural polymer-based hydrogels can be derived from proteins, such as collagen and fibrin, as well as polysaccharides, such as hyaluronic acid, alginate, chitosan, and cellulose. Hydrogels composed of individual ECM polymers and combinations thereof have been applied to create simple culture systems.

Type I collagen, as the most abundant protein present in mammals, has been extensively investigated, is readily available, and has been approved by the United States Food and Drug Administration (FDA) for several applications. Collagen hydrogels have been applied in ASC-derived small intestinal, stomach, and colonic organoids (12-15) and in human PSC-derived polycystic kidney disease organoids (15). Small intestinal organoids grow as budding cysts in Matrigel droplets, but display a smooth appearance without buds and often form a monolayer with an enteroid pattern when grown in collagen (12, 14). Moreover, when cultured in a floating collagen ring, organoids fuse and form a continuous macroscopic structure. Recently, floating collagen hydrogel culture of single primary human mammary epithelial cells was shown to induce the formation of branched multicellular organoids (16). During branch elongation, cells invade the collagen matrix by branch-internal collective cell migration until branch outgrowth stops, forming alveoli-like end buds. Movement of cells within the branches causes tension that induces the reorganization of the surrounding collagen meshwork and leads to the formation of a mechanically stable cage. This collagen casing was shown to induce more tension and promote branch elongation and collagen deformation, thereby creating spatial confi-nement. In another study by Sachs et al. (13), collagen was used to create macroscopic structures out of organoids by culturing intestinal organoids in a floating collagen ring. They found that the organoids fused and formed a continuous large-scale construct.

Alginate, a seaweed-derived polysaccharide, has also been used as a hydrogel to support intestinal (17) and islet organoid culture (18). Alginate precursor solution was gelled by the ionotropic method (i.e. exposed to CaCl2 (17) or BaCl2 (18) solution). Organoids cultured in alginate hydrogel promoted viability, crypt structure, and protein expression comparable to Matrigel. However, organoid yields were lower for cells cultured with alginate when maintained for a longer term. Because of its inert nature, low toxicity, ease of gelation, and tunable properties, alginate has been approved for use by the FDA and has been widely used for cell encapsulation. However, alginate alone lacks cell recognition sites and signaling proteins provided by the ECM.

Multiple isolated ECM proteins and carbohydrate components can also be used to prepare 3D scaffolds. For example, Curvello et al. (19) designed an ECM multicom-posite hydrogel by mixing collagen with RGD (Arg-Gly-Asp) peptide-functionalized cellulose nanofibers to promote the formation and growth of intestinal orga-noids. RGD peptide was first grafted to cellulose fibers by EDC/NHS coupling, and the resulting RGD-nanocellulose pre-gel solution was then physically mixed with pH-adjusted collagen pre-gel solution. Gelation was then induced via physiological temperature that promoted collagen fibril assembly driven by an increase in entropy (19). Crypts embedded in collagen-RGD-nanocellulose hydrogel were found to form organoids with clear epithelial budding, and the resulting cell viability and metabolic activity of the organoids were comparable to those of organoids cultured in Matrigel. Additionally, Sokol et al. (20) generated ECM hydrogels composed of type I collagen, hyaluronan, laminin, and fibronectin to provide adhesion sites and support breast organoid formation (20). This hydrogel closely mimicked the in vivo environment in a simplistic and defined way. In terms of structural integrity, the proteins of the composite, including collagen, laminin, and fibronectin, provide tensile strength, whereas the carbohydrate hyaluronan resists compressive forces. Overall, this multicomponent ECM hydrogel was found to have a higher swelling ratio and elastic modulus compared with collagen hydrogel alone, likely owing to the inclusion of hyaluronans. When seeded in the ECM hydrogel, mammary epithelial cells were found to self-organize, expand, and form complex ductal and lobular morphologies resembling epithelial structures of human tissues. By contrast, ductal growth was limited when seeded in collagen or Matrigel. More recently, Homan et al. (21) developed human iPSC-derived vascularized kidney organoids by optimizing ECM, medium composition, fluidic shear stress, and coculture with endothelial cells in a millifluidic culture system. Partial embedding of developing kidney organoids in a thick layer of gelatin and fibrin matrices was shown to enhance the peripheral expression of vascular markers compared with a layer composed of fibrin alone or with type I collagen. Broguiere et al. (22) investigated whether well-defined matrices could support various epithelial organoids comparable to Matrigel. The authors modified polyethylene glycol (PEG), hyaluronan, alginate, and fibrin hydrogels to become degradable or deformable, reasoning that the organoids would require physical space as they increased in size during culture (22). PEG and hyaluronan gels contained a matrix metalloproteinase (MMP)-sensitive peptide sequence, whereas alginate was weakly crosslinked, and fibrin was inherently degradable. Among the four scaffolds supplemented with 10% (v/v) Matrigel, fibrin showed small intestinal organoid formation efficiency similar to that of pure Matrigel. In order to completely eliminate the use of Matrigel in the hydrogel system, fibrin was supplemented with the main ECM components of Matrigel: collagen IV, heparin, and laminin-111/entactin complex (22). Fibrinogen and low content of nanofibrillar cellulose was supplemented with various ECM proteins and polymerization was induced by adding thrombin. The nanocellulose was added to increase the viscosity during gelation to prevent the sedimentation of organoids. Out of ECM components, laminin was found to be the critical signaling molecule required for fibrin-laminin hydrogel-supported long-term expansion of small intestinal, pancreatic, and liver organoids comparable to that in pure Matrigel (22).

Naturally-derived materials from decellularized tissues have several advantages for hydrogel formation. Dec-ellularized tissue ECM (dECM) preserves important biochemical signals, such as growth factors, glycans, bioactive cryptic peptides, and natural proteins that are fundamental for cell growth, differentiation, and function (23, 24). Decellularized tissues are approved by the FDA and have been already used clinically for tissue regeneration (25). Hydrogels derived from decellularized tissue also have the advantage of being good manufacturing practice-compliant and FDA-approved (26). Decellularization is commonly accomplished by chemical, enzymatic, and/or physical methods (27). After the decellularization step, decellularized tissues are dehydrated, and the resulting powder is then solubilized into protein monomeric components (26). The most prevalent method used to solubilize the powder form of dECM is to use pepsin in an acidic condition. The solubilized dECM is then neutralized to physiologic pH, salt concentration and temperature dominated by collagen assembly (26). dECM-based hydrogels have been used for the culture of brain (28, 29), endodermal (30, 31), islet (32, 33), retinal (34), testicular (35), and endometrial (36) organoids. Additionally, Giobbe et al. (31) demonstrated that endoderm-derived organoids, including small intestinal, gastric, hepatic, and pancreatic organoids, could be cultured in the decellularized porcine small intestine mucosa/submucosa. Compared with endodermal organoids cultured in Matrigel, no significant differences were observed in terms of viability and morphology during the first 3∼4 passages. Transcriptomic analysis of human pediatric small intestinal organoids revealed that the expression of crypt stem cell markers was upregulated in the dECM hydrogel, whereas some of the differentiated intestinal cells were slightly upregulated in Matrigel. The dECM has also been used for brain organoid culture (28, 29). Decellularized human brain ECM (BEM) was shown to provide important biochemical and biophysical cues necessary to guide brain organogenesis at an early phase (29). The authors observed that brain organoids encapsulated in BEM exhibited enhanced proliferation of neural progenitors and increased neuronal differentiation. These organoids displayed well-organized structures with enhanced radial polarity.

The downstream translational application of ECM-derived hydrogels is related to the high variability of laboratory-derived products. Cho et al. (29) investigated the variability of human BEM by examining batch variation (different tissue batches derived from the same donor), sample variation (tissues derived from different donors), and regional variation (tissues derived from different brain regions) by proteomic analysis. The authors found substantial differences in ECM composition between different brain regions, whereas batch-to-batch variation arising from the decellularization process and different donor samples was relatively low. The variability of dECM-derived hydrogels may arise after lyophilization, including solubilization of the dECM powder and gelation of the dECM solution. A study by Dorgau et al. (34) used decellularized neural retina and retinal pigment epithelium ECM as culture medium supplements to guide retinal organogenesis. Supplementation with dECM was shown to enhance the functionality of retinal organoids, including increased ribbon synapse marker expression and light responsiveness. Bi et al. (32) investigated the key ECM components in dECM hydrogels to develop chemically defined materials for islet organoid development and showed that type V collagen was abundantly present in the decellularized pancreatic ECM hydrogel. Type V collagen shows tissue-specific distribution and is highly conserved in the pancreas across species. In the presence of type V collagen in 2D substrates, human iPSCs self-assembled to form islet organoids with enhanced islet-related gene expression and secretion of insulin and glucagon in response to glucose.

Given limitations in processability and the complexity of natural matrices, chemically defined synthetic polymer hydrogels have emerged. Although synthetic-based materials cannot yet recapitulate the complexity of the ECM in vivo, precise control and consistent fabrication processes confer organoid cultures with high reproducibility. Recently, several hydrogel systems have been developed with tunable properties to mimic mechanical, rheological, and chemical factors. The common synthetic polymers that have been reported include PEG (37-44), poly (lactic-co-glycolic acid) (PLGA) (45, 46), polycaprolactone (PCL) (45, 47), poly (N-isopropylacrylamide) (pNIPAM) (47), and poly (vinyl alcohol) (PVA) (48). Synthetic polymers are often functionalized with cell-adhesive peptides and sequences that can be cleaved by MMP via chemical/enzymatic crosslinking to mimic specific cell-cell interactions relevant to morphogenetic processes.

Gjorevski et al. (41, 42) introduced a PEG-based hydrogel system that can support intestinal stem cell expansion and differentiation into organoids. In this system, RGD and laminin-111 were conjugated to PEG as minimal adhesive ligands. The authors also designed a mechanically dynamic system by blending mechanically static PEG-vinylsulfone and hydrolytically degradable PEG-acrylate. This hybrid hydrogel was found to afford initial high stiffness (≈ 1.3 kPa) to promote the cell expansion and subsequently soften (≈ 200 Pa) to alleviate the accumulation of compressive forces and promoted organoid formation with differentiated phenotype. A subsequent study reported a completely synthetic hydrogel system based on four-arm PEG with maleimide groups at each terminus, and functionalized with bioactive ligands (e.g. RGD adhesive peptide) and crosslinked with the protease-degradable peptide GPQ-W (37, 39). This PEG-based hydrogel supported viability and expansion of intestinal organoids. Delivery of human PSC-derived intestinal organoids to intestinal wounds using a murine colonoscope resulted in successful organoid survival, engraftment, and wound repair (39). This same PEG hydrogel system could also be applied to culture lung organoids. In another study, mouse and human intestinal crypts embedded in functionalized PEG hydrogels have demonstrated to support organoid growth (40). Eight-arm PEG was modified with integrin α2β1 ligand GFOGERRGD and crosslinked with MMP-sensitive peptide. The resulting PEG-based hydrogel supported long term culture of the organoids, but the proliferation rate was relatively lower compared to that in Matrigel (40). A more recent study demonstrated that PEG-based hydrogel could support differentiation of human liver organoids (43). In this study, gelatin and PEG were covalently crosslinked enzymatically via coagulation factor XIIIa (FXIIIa). FXIII-specific amino acid sequence was conjugated to 8 arm PEG which was crosslinked with the native lysine residues on gelatin. Coupling of laminin 111 via naturally occurring lysine residues on the protein into the PEG-based hydrogel improved liver organoid differentiation and function. These studies have demonstrated that both mechanical and biochemical properties were important for the organoid formation and expansion (39, 40, 43). The presence of adhesive sites and degradable sites were the fundamental in these matrices. Other fully synthetic polymers have been applied for intestinal organoid culture. NIPAM-Laponite clay nanoparticles were shown to result in the formation of spherical shapes with no central lumen (47). This hydrogel system seemed to support intestinal organoid growth with buds only after initial culture in Matrigel.

Synthetic polymers can also be used as a nonhydrogel system. For example, a 2D PEG-based micropatterned substrate was used to induce geometric confinement during cardiac differentiation of human iPSCs (38). With the optimal geometric confinement, spatially organized cardiac organoids were generated with cardiomyocytes present in the center, surrounded by stromal cells distributed along the pattern perimeter. Geometric confinement could be provided by a PEG-based micropatterned substrate. PEG can also be used as a 2D substrate coating material to promote attachment of intestinal organoid epithelium on a hydrophobic polydimethylsiloxane-based microdevice (49). In another case, PLGA microfilaments were used as a floating scaffold to generate elongated embryoid bodies, resulting in improved neuroectoderm formation and cortical development in human iPSC-derived cerebral organoids (50).

The development of organoids has been a major breakthrough in simulating physiological organ architecture in vitro. Organoid technology can be used in various applications, including drug development, toxicity screening, disease modeling, and cell therapy. Moreover, the use of organoids can address fundamental biological questions. Matrigel is commonly used as a universal matrix for the generation of almost all types of organoids without considering the effects of tuning tissue-specific factors. Various alternative scaffold systems have recently been designed to meet the needs of organoid culture its use in clinical applications.

Each system has advantages and drawbacks for organoid cultures (Table 2). Natural polymers often provide high biocompatibility, biodegradability, low toxicity, and specific signaling cues. In order to reduce complexity and increase reproducibility, natural single polymers have been employed for organoid culture. These components are derived from the ECM, and some are bioactive; however, further in-depth studies are required to determine whether these systems support long-term organoid growth and differentiation similar to Matrigel. Moreover, these polymers often show limited processability and exhibit relatively poor rheological properties. Naturally-derived dECM hydrogels retain important biochemical signals of the tissue of origin that can support organoid growth and differentiation. Similar to Matrigel, the control of batch-to-batch variation and tunability still need to be addressed. Recently, Cho et al. (29) suggested that the variability of dECM composition may arise from the isolated region of the tissue. Hence, reproducibility may be improved by standardizing the tissue isolation process. Synthetic polymers have several advantages that these systems are xeno-free, chemically defined and reproducible, thus guarantee higher levels of experimental accuracy. In order to increase bioactivity, synthetic matrices can be functionalized to promote cell adhesion and cell-driven matrix remodeling. In contrast to natural polymers, the mechanical properties and chemical composition of synthetic polymers can be precisely modulated and almost independently of each other. These properties offer a powerful platform to deconstruct the complexity of native microenvironments and define their key instructive signals. The effects of individual or combinations of various cues can be probed systematically to study particular biological processes during organogenesis. However, synthetic matrices can only partially reproduce some native ECM features with low number of biologically active sites. Additionally, synthetic systems cannot easily achieve multifactorial parameters for directing cell behaviors in organoid cultures.

Table 2 . Advantages and disadvantages of biomaterials for organoid culture.

	Matrigel	Natural polymers	dECM	Synthetic polymers
Advantages	Built-in complex mixture of nutrients and proteins Readily available commercialized product Easy to handle	Inertness Low toxicity Biodegradability	Low toxicity Closely mimics native ECM High bioactivity Biodegradability	Chemically defined Xenogeneic-free Tunable mechanical and degradation properties
Disadvantages	Not clinically applicable Poorly defined Low mechanical strength Lot-to-lot variability Lacks tissue-specific ECM compositions	Low mechanical strength Lacks tissue-specific ECM compositions	Poorly defined Low mechanical strength Rapid degradation	Low bioactivity Low cell adhesion Lacks tissue-specific ECM compositions Difficult and expensive synthesis procedure

We have reviewed the use of several hydrogel systems for organoid culture (Table 1). Despite of the rapid progress, the development of the organoid culture systems is still in the infant stage. The ECM is chemically and physically dynamic via numerous binding sites, and mimicry of this complexity for organoid culture remains a challenge. There are several potential strategies to overcome the fundamental limitations of each type of hydrogel systems, but yet have not been validated for organoid culture. For example, the dECM can also be modified with methacrylate (51) and catechol moieties (52) to enhance mechanical and adhesive characteristics. Natural polymers could be combined with synthetic polymers, creating hybrid polymers to provide various physicochemical and biological characteristics, which may compensate the synergic effect between synthetic and natural polymeric constituents. A dual-stage polymerization system, composed of thiolated dECM and PEG-acrylate, having large number of biologically active sties and dynamic mechanical properties (53), could be employed to mimic mechanical changes during tissue development or disease progression. We envisage that ongoing expansive development of advanced hydrogel systems that leads to the generation of multifactorial signals that encode the constraints of dynamic tissue-specific cues, and in depth validation of the reliability of specific composite hydrogels for organoid cultures will be crucial to make practical differences across numerous downstream applications.

This work was supported by a grant from the National Research Foundation of Korea (NRF; grant no. 2021R1 C1C2009131) funded by the Ministry of Science and ICT (MSIT), Republic of Korea. This study was also supported by a new faculty research seed money grant (6-2021-0243) of Yonsei University College of Medicine for 2021. Illustrations in Table 1 were created with BioRender.com.

The authors have no conflicting financial interests.